Naloxone B. Braun (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone B. Braun, is an opioid antagonist presented as a sterile injectable solution for intramuscular and intravenous use. It rapidly reverses the effects of opioid overdose and is employed in emergency settings for patients of all ages.

GNH USA supplies Naloxone B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone is an opioid antagonist used to counteract life‑threatening effects of opioid exposure. - Opioid overdose: rapid reversal of respiratory depression and sedation. - Opioid‑induced respiratory depression: restores adequate breathing in acute settings. - Accidental opioid exposure: counteracts opioid effects in unintentional ingestion or injection.

Naloxone is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Sweating: increased diaphoresis following administration. - Tachycardia: transient elevation of heart rate. - Headache: mild to moderate headache may be reported.

Serious or Rare Side Effects: - Severe hypertension: abrupt rise in blood pressure requiring monitoring. - Cardiac arrhythmia: irregular heart rhythms in susceptible individuals. - Seizures: rare convulsive episodes, especially with high doses. - Pulmonary edema: fluid accumulation in lungs, a rare emergency. - Anaphylaxis: severe allergic reaction requiring immediate treatment.

Naloxone should be used with careful clinical assessment and monitoring. - Assess opioid dependence: anticipate possible acute withdrawal symptoms. - Confirm opioid overdose before administration: avoid unnecessary antagonism. - Monitor cardiovascular status: watch for hypertension or tachycardia. - Avoid in patients with known hypersensitivity to naloxone or formulation components. - Use with caution in patients with underlying cardiac disease. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxone may interact with other drugs that affect the central nervous system or cardiovascular function.

Major Interactions (Avoid): - Concurrent potent opioid agonists: can precipitate severe withdrawal. - Mixed agonist‑antagonist opioids (e.g., pentazocine): reduced efficacy of naloxone. - Drugs that lower seizure threshold (e.g., bupropion): increased risk of seizures.

Moderate Interactions (Monitor Closely): - Benzodiazepines: may mask opioid reversal, requiring additional monitoring. - Tricyclic antidepressants: additive cardiovascular effects. - Alcohol: may enhance central nervous system depression after reversal.